ESR1 and breast carcinoma: LMTK3, a key ERα regulator in breast cancer, stabilizes ERα via direct phosphorylation and promotes its transcription by inhibiting PKC, reducing AKT phosphorylation, and facilitating FOXO3 binding to the ESR1 promoter (157–159).